|
|
|
Sunday, March 8, 2009 — 1:30 PM, Convention Center 302
|
- The Role of Molecular Genetics and Cytogenetics in Tumors of the Soft Tissue and Bone
|
|
Moderator:
|
Angelo P. Dei Tos, General Hospital of Treviso, Treviso, Italy
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. The speakers listed below have indicated they have nothing to disclose.
|
Click the button above to add this event to your Itinerary Planner...
 Click here to view (or print) handout in single page format for the entire meeting.
Note: Any slides will be printed in color.
Click here to view (or print) black and white handout for the entire meeting
Note: Text will be in single page format and any slides will be in 6-per-page format.
Click any blue title below to display and print the handout for individual lecture(s):
| 1:30 | Opening Remarks - Angelo P. Dei Tos, General Hospital of Treviso, Treviso, Italy |
| 1:35 | Using Signaling Pathways to Identify Targets in Soft Tissue Sarcomas - Jonathan Fletcher, Brigham and Woman's University, Boston, MA |
| 2:05 | Patterns of Resistance in GIST: Implications for Genetic Testing and Therapeutics - Christina R. Antonescu, Memorial Sloan-Kettering Cancer Center, New York, NY |
| 2:35 | Clinical Applications of Gene Expression Profiling in Soft Tissue Tumors - Robert B. West, Stanford University, Stanford, CA |
| 3:05 | Break |
| 3:30 | Application of FISH in Soft Tissue Sarcoma Diagnosis - Andre M. Oliveira, Mayo Clinic, Rochester, MN |
| 4:00 | Clinical Relevance of Molecular Genetics in Bone Tumors - Pancras C. W. Hogendoorn, Leiden University Medical Center, Leiden, The Netherlands |
| 4:30 | Prognostic Relevance of Molecular Genetics in Soft Tissue Tumors - Poul H. Sorensen, Women's and Children's Hospital, Vancouver, Canada |
| 5:00 | Conclusive Remarks - Christopher D. M. Fletcher, Brigham and Woman's Hospital, Boston, MA |
|
Topics are proposed and then selected by the Society’s officers considering timeliness as well as impact over bone and soft tissue tumor pathology practice, trying to avoid overlap with topics discussed in previous meetings. The integration of conventional morphology with molecular genetics represents one of the major recent advances in the field of bone and soft tissue pathology. This meeting will focus upon the clinical impact of molecular genetics and will try to elucidate how new techniques can be currently used in order to improve diagnosis, prognostic stratification and therapeutic planning.
|
|
|
|
